219 related articles for article (PubMed ID: 21529986)
21. The Predictive Value of ERCC1, RRM1, and Thymidylate Synthase in Advanced Malignant Pleural Mesothelioma Patients Treated with Platinum-Based Chemotherapy.
Wahba NI; Khorshid O; Abo Elkasem F; Bahnassy A; Gaafer R
Asian Pac J Cancer Prev; 2023 Jan; 24(1):195-205. PubMed ID: 36708568
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.
Mlak R; Krawczyk P; Ramlau R; Kalinka-Warzocha E; Wasylecka-Morawiec M; Wojas-Krawczyk K; Kucharczyk T; Homa I; Kozioł P; Ciesielka M; Chudziak D; Milanowski J
Oncol Rep; 2013 Nov; 30(5):2385-98. PubMed ID: 23982437
[TBL] [Abstract][Full Text] [Related]
23. Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.
Bepler G; Williams C; Schell MJ; Chen W; Zheng Z; Simon G; Gadgeel S; Zhao X; Schreiber F; Brahmer J; Chiappori A; Tanvetyanon T; Pinder-Schenck M; Gray J; Haura E; Antonia S; Fischer JR
J Clin Oncol; 2013 Jul; 31(19):2404-12. PubMed ID: 23690416
[TBL] [Abstract][Full Text] [Related]
24. Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer.
Mok T; Ladrera G; Srimuninnimit V; Sriuranpong V; Yu CJ; Thongprasert S; Sandoval-Tan J; Lee JS; Fuerte F; Shames DS; Klughammer B; Truman M; Perez-Moreno P; Wu YL
Lung Cancer; 2016 Aug; 98():1-8. PubMed ID: 27393499
[TBL] [Abstract][Full Text] [Related]
25. Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy.
Leng XF; Chen MW; Xian L; Dai L; Ma GY; Li MH
J Exp Clin Cancer Res; 2012 Mar; 31(1):25. PubMed ID: 22439756
[TBL] [Abstract][Full Text] [Related]
26. Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy.
Vassalou H; Stathopoulos E; Fiolitaki G; Koutsopoulos A; Voutsina A; Georgoulias V; Mavroudis D
Lung Cancer; 2013 Nov; 82(2):324-9. PubMed ID: 23993732
[TBL] [Abstract][Full Text] [Related]
27. ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer.
Su C; Zhou S; Zhang L; Ren S; Xu J; Zhang J; Lv M; Zhang J; Zhou C
Med Oncol; 2011 Dec; 28(4):1411-7. PubMed ID: 20467918
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer.
Zhang Q; Zhu X; Zhang L; Sun S; Huang J; Lin Y
Cancer Chemother Pharmacol; 2014 Oct; 74(4):839-46. PubMed ID: 25119181
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of EGFR mutation and ERCC1 in patients with non-small cell lung cancer undergoing platinum-based chemotherapy.
Yamashita F; Azuma K; Yoshida T; Yamada K; Kawahara A; Hattori S; Takeoka H; Zaizen Y; Kawayama T; Kage M; Hoshino T
PLoS One; 2013; 8(8):e71356. PubMed ID: 23940741
[TBL] [Abstract][Full Text] [Related]
30. ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Booton R; Ward T; Ashcroft L; Morris J; Heighway J; Thatcher N
J Thorac Oncol; 2007 Oct; 2(10):902-6. PubMed ID: 17909351
[TBL] [Abstract][Full Text] [Related]
31. Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.
Rosell R; Felip E; Taron M; Majo J; Mendez P; Sanchez-Ronco M; Queralt C; Sanchez JJ; Maestre J
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4215s-4219s. PubMed ID: 15217961
[TBL] [Abstract][Full Text] [Related]
32. A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.
Heo SJ; Jung I; Lee CK; Kim JH; Lim SM; Moon YW; Shim HS; Jeong J; Kim JH; Kim HR; Cho BC
Cancer Chemother Pharmacol; 2016 Mar; 77(3):539-48. PubMed ID: 26811178
[TBL] [Abstract][Full Text] [Related]
33. Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
Lee SM; Falzon M; Blackhall F; Spicer J; Nicolson M; Chaudhuri A; Middleton G; Ahmed S; Hicks J; Crosse B; Napier M; Singer JM; Ferry D; Lewanski C; Forster M; Rolls SA; Capitanio A; Rudd R; Iles N; Ngai Y; Gandy M; Lillywhite R; Hackshaw A
J Clin Oncol; 2017 Feb; 35(4):402-411. PubMed ID: 27893326
[TBL] [Abstract][Full Text] [Related]
34. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.
Lord RV; Brabender J; Gandara D; Alberola V; Camps C; Domine M; Cardenal F; Sánchez JM; Gumerlock PH; Tarón M; Sánchez JJ; Danenberg KD; Danenberg PV; Rosell R
Clin Cancer Res; 2002 Jul; 8(7):2286-91. PubMed ID: 12114432
[TBL] [Abstract][Full Text] [Related]
35. PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.
Papadaki C; Sfakianaki M; Lagoudaki E; Giagkas G; Ioannidis G; Trypaki M; Tsakalaki E; Voutsina A; Koutsopoulos A; Mavroudis D; Georgoulias V; Souglakos J
Br J Cancer; 2014 Oct; 111(9):1757-64. PubMed ID: 25233397
[TBL] [Abstract][Full Text] [Related]
36. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
Moran T; Wei J; Cobo M; Qian X; Domine M; Zou Z; Bover I; Wang L; Provencio M; Yu L; Chaib I; You C; Massuti B; Song Y; Vergnenegre A; Lu H; Lopez-Vivanco G; Hu W; Robinet G; Yan J; Insa A; Xu X; Majem M; Chen X; de Las Peñas R; Karachaliou N; Sala MA; Wu Q; Isla D; Zhou Y; Baize N; Zhang F; Garde J; Germonpre P; Rauh S; ALHusaini H; Sanchez-Ronco M; Drozdowskyj A; Sanchez JJ; Camps C; Liu B; Rosell R; ; Colinet B; De Grève J; Germonpré P; Chen H; Chen X; Du J; Gao Y; Hu J; Hu W; Kong W; Li L; Li R; Li X; Liu B; Liu J; Lu H; Qian X; Ren W; Song Y; Wang L; Wei J; Wen L; Wu Q; Xiao X; Xu X; Yan J; Yang J; Yang M; Yang Y; Yin J; You C; Yu L; Yue X; Zhang F; Zhang J; Zhou Y; Zhu L; Zou Z; Baize N; Bombaron P; Chouaid C; Dansin E; Fournel P; Fraboulet G; Gervais R; Hominal S; Kahlout S; Lecaer H; Lena H; LeTreut J; Locher C; Molinier O; Monnet I; Oliviero G; Robinet G; Schoot R; Thomas P; Vergnènegre A; Berchem G; Rauh S; Al Husaini H; Aparisi F; Arriola E; Ballesteros I; Barneto I; Bernabé R; Blasco A; Bosch-Barrera J; Bover I; Calvo de Juan V; Camps C; Carcereny E; Catot S; Cobo M; De Las Peñas R; Dómine M; Felip E; García-Campelo MR; García-Girón C; García-Gómez R; Garcia-Sevila R; Garde J; Gasco A; Gil J; González-Larriba JL; Hernando-Polo S; Jantus E; Insa A; Isla D; Jiménez B; Lianes P; López-López R; López-Martín A; López-Vivanco G; Macias JA; Majem M; Marti-Ciriquian JL; Massuti B; Montoyo R; Morales-Espinosa D; Morán T; Moreno MA; Pallares C; Parera M; Pérez-Carrión R; Porta R; Provencio M; Reguart N; Rosell R; Rosillo F; Sala MA; Sanchez JM; Sullivan I; Terrasa J; Trigo JM; Valdivia J; Viñolas N; Viteri S; Botia-Castillo M; Mate JL; Perez-Cano M; Ramirez JL; Sanchez-Rodriguez B; Taron M; Tierno-Garcia M; Mijangos E; Ocaña J; Pereira E; Shao J; Sun X; O'Brate R
Ann Oncol; 2014 Nov; 25(11):2147-2155. PubMed ID: 25164908
[TBL] [Abstract][Full Text] [Related]
37. Predictive role of RRM1 and BRCA1 mRNA expression on the clinical outcome of advanced non-small cell lung cancer.
Liang JG; Jin ZY; Gao XD; Te MR; Ge LH; Wang CL
Genet Mol Res; 2014 Jul; 13(3):5292-8. PubMed ID: 25078585
[TBL] [Abstract][Full Text] [Related]
38. Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).
Kotoula V; Krikelis D; Karavasilis V; Koletsa T; Eleftheraki AG; Televantou D; Christodoulou C; Dimoudis S; Korantzis I; Pectasides D; Syrigos KN; Kosmidis PA; Fountzilas G
BMC Cancer; 2012 Aug; 12():342. PubMed ID: 22866924
[TBL] [Abstract][Full Text] [Related]
39. Expression of ERCC1 and BRCA1 predict the clinical outcome of non-small cell lung cancer in patients receiving platinum-based chemotherapy.
Wang TB; Zhang NL; Wang SH; Li HY; Chen SW; Zheng YG
Genet Mol Res; 2014 May; 13(2):3704-10. PubMed ID: 24854656
[TBL] [Abstract][Full Text] [Related]
40. mRNA expression and clinical significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in postoperative patients with non-small cell lung cancer.
Han Y; Wang XB; Xiao N; Liu ZD
Asian Pac J Cancer Prev; 2013; 14(5):2987-90. PubMed ID: 23803067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
